ALQGC — Quantum Genomics SA Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Quantum Genomics receives two new patents in the United States
Brief: Quantum genomics receives authorisation to begin Phase IIA multicentric European trial
Brief: Quantum Genomics raises 8.6 million euros
Brief: Quantum Genomics announces capital increase
Brief: Quantum Genomics: new patent approved for United States
Brief: Quantum Genomics completes patient enrolment for phase IIa QGC001 trial
Brief: Quantum Genomics' Scientific Advisory Board recommends next multicentric clinical trials
Brief: Quantum Genomics H1 net loss widens to 1.8 mln euros
Brief: Quantum Genomics gets positive opinion of Monitoring Board for study of high blood pressure
Brief: Quantum Genomics announces 50 pct enrolment in QGC001 phase IIa trial
Brief: Quantum Genomics signs research collaborations
Brief: Quantum Genomics obtains positive results with heart failure study in dogs
Brief: Quantum Genomics announces creation of a joint laboratory at College de France
Brief: Quantum Genomics says final amount of capital increase is 12.9 mln euros
Brief: Quantum Genomics raises 11.2 million euros in IPO
Brief: Quantum Genomics launches 9.1 mln euro capital increase
Brief: Trading on Quantum Genomics shares is suspended - Euronext
Brief: Quantum Genomics appoints Dr. Olivier Madonna as Medical Director
Brief: Quantum Genomics receives regulatory approval to start phase II trial in hypertension